Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Prev Chronic Dis ; 20: E46, 2023 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-37290008

RESUMO

Numerous studies have supported the effectiveness and cost-effectiveness of quitlines for cigarette smoking cessation, but how effective they are for vaping cessation has not been established. Our secondary analysis examined quitline data on participants in employer-sponsored quitlines in the US run by Optum, Inc to compare quit rates among callers who were exclusive vapers (n = 1,194) with those who were exclusive smokers (n = 22,845). We examined data from the time of quitline enrollment, January 2017, through October 2020. Before adjusting for differences in demographics, quitline treatment engagement, and unadjusted quit rates, the quit rates for vapers were significantly higher. However, after adjusting for demographic and treatment engagement variables, 6-month quit rates among vapers did not differ significantly from rates among smokers.


Assuntos
Fumantes , Abandono do Hábito de Fumar , Humanos , Aconselhamento , Linhas Diretas
2.
Prog Community Health Partnersh ; 16(3): 321-329, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36120875

RESUMO

BACKGROUND: American Indian/Alaska Native (AI/AN) cigarette smoking prevalence is disproportionately high, especially in the northern United States. Tailored quitlines are needed to support AI/AN commercial tobacco users with quitting. OBJECTIVES: Obtain community feedback by working with trusted AI/AN partners; genuinely incorporate feedback into program design; collaboratively develop and implement culturally relevant quitline services for Minnesota's AI/AN community. METHODS: Working in partnership, AI/AN community input was gathered, and community partners were engaged to inform the development, training, implementation and monitoring of a tailored program within the existing state quitline. RESULTS: Findings suggest focusing on the commercial tobacco user/coach relationship, increased cultural understanding and program content adaptations could make quitlines more acceptable for AI/AN commercial tobacco users. CONCLUSIONS: The development and launch of the AI Quitline demonstrated the feasibility of collaboration among AI/AN organizations and community members, funders and providers to create a culturally relevant cessation service for AI/AN commercial tobacco users.


Assuntos
Indígenas Norte-Americanos , Tabagismo , Pesquisa Participativa Baseada na Comunidade , Retroalimentação , Humanos , Nicotiana , Estados Unidos/epidemiologia , Indígena Americano ou Nativo do Alasca
3.
Artigo em Inglês | MEDLINE | ID: mdl-33801227

RESUMO

Tobacco use is projected to kill 1 billion people in the 21st century. Tobacco Use Disorder (TUD) is one of the most common substance use disorders in the world. Evidence-based treatment of TUD is effective, but treatment accessibility remains very low. A dearth of specially trained clinicians is a significant barrier to treatment accessibility, even within systems of care that implement brief intervention models. The treatment of TUD is becoming more complex and tailoring treatment to address new and traditional tobacco products is needed. The Council for Tobacco Treatment Training Programs (Council) is the accrediting body for Tobacco Treatment Specialist (TTS) training programs. Between 2016 and 2019, n = 7761 trainees completed Council-accredited TTS training programs. Trainees were primarily from North America (92.6%) and the Eastern Mediterranean (6.1%) and were trained via in-person group workshops in medical and academic settings. From 2016 to 2019, the number of Council-accredited training programs increased from 14 to 22 and annual number of trainees increased by 28.5%. Trainees have diverse professional backgrounds and work in diverse settings but were primarily White (69.1%) and female (78.7%) located in North America. Nearly two-thirds intended to implement tobacco treatment services in their setting; two-thirds had been providing tobacco treatment for 1 year or less; and 20% were sent to training by their employers. These findings suggest that the training programs are contributing to the development of a new workforce of TTSs as well as the development of new programmatic tobacco treatment services in diverse settings. Developing strategies to support attendance from demographically and geographically diverse professionals might increase the proportion of trainees from marginalized groups and regions of the world with significant tobacco-related inequities.


Assuntos
Nicotiana , Produtos do Tabaco , Feminino , Humanos , América do Norte , Especialização , Uso de Tabaco/epidemiologia , Recursos Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA